Back
Edgewise Therapeutics Stock Price Chart

AI Is Disrupting Marketing—Invest Before April 10!
⏳ Secure Your Stake in AI Marketing Before This Window Closes!
Sell
7
EWTX
Edgewise Therapeutics
Last Price:
$20.10
Seasonality Move:
-3.3%
7 Day Trial
ALL ACCESS PASS
$
7

Apple's Drop in iPhone Sales Opens the Door for New Entrant
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EWTX is experiencing slight selling pressure.
Edgewise Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.07 | Sell |
20-day SMA: | 24.93 | Sell |
50-day SMA: | 26.25 | Sell |
200-day SMA: | 25.28 | Sell |
8-day EMA: | 23.26 | Sell |
20-day EMA: | 24.45 | Sell |
50-day EMA: | 25.92 | Sell |
200-day EMA: | 24.82 | Sell |
Edgewise Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.1 | Sell |
Relative Strength Index (14 RSI): | 34.61 | Sell |
Chaikin Money Flow: | -573787 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.44 - 26.86) | Sell |
Bollinger Bands (100): | (25.14 - 31.96) | Sell |
Edgewise Therapeutics Technical Analysis
Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Edgewise Therapeutics Stock
Is Edgewise Therapeutics Stock a Buy?
-
Edgewise Therapeutics share price is 22.00 while EWTX 8-day simple moving average is 23.07, which is a Sell signal.
-
The stock price of EWTX is 22.00 while Edgewise Therapeutics 20-day SMA is 24.93, which makes it a Sell.
-
Edgewise Therapeutics 50-day simple moving average is 26.25 while EWTX share price is 22.00, making it a Sell technically.
-
EWTX stock price is 22.00 and Edgewise Therapeutics 200-day simple moving average is 25.28, creating a Sell signal.
EWTX Technical Analysis vs Fundamental Analysis
Sell
7
Edgewise Therapeutics (EWTX)
is a Sell
Is Edgewise Therapeutics a Buy or a Sell?
-
Edgewise Therapeutics stock is rated a SellThe current Edgewise Therapeutics [EWTX] share price is $22.00. The Score for EWTX is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
Edgewise Therapeutics Stock Info
Market Cap:
2.1B
Price in USD:
22.00
Share Volume:
1.5M
Edgewise Therapeutics 52-Week Range
52-Week High:
38.12
52-Week Low:
14.90
Sell
7
Edgewise Therapeutics (EWTX)
is a Sell
Edgewise Therapeutics Share Price Forecast
-
What is the Edgewise Therapeutics stock price today?The Edgewise Therapeutics stock price is 22.00 USD today.
-
Will EWTX stock go up or go down?Edgewise Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Edgewise Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Edgewise Therapeutics is overvalued.
Is Edgewise Therapeutics Stock a Buy?
-
Edgewise Therapeutics share price is 22.00 while EWTX 8-day exponential moving average is 23.26, which is a Sell signal.
-
The stock price of EWTX is 22.00 while Edgewise Therapeutics 20-day EMA is 24.45, which makes it a Sell.
-
Edgewise Therapeutics 50-day exponential moving average is 25.92 while EWTX share price is 22.00, making it a Sell technically.
-
EWTX stock price is 22.00 and Edgewise Therapeutics 200-day simple moving average is 24.82, creating a Sell signal.
Fundamental Analysis of Edgewise Therapeutics
Is Edgewise Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.41 per share, and a decrease next year of $0.35 per share.
Technical Analysis of Edgewise Therapeutics
Should I short Edgewise Therapeutics stock?
-
EWTX Moving Average Covergence Divergence (MACD) indicator is -1.1, suggesting Edgewise Therapeutics is a Sell
-
Edgewise Therapeutics Relative Strength Index (RSI) is 34.61, which suggest Edgewise Therapeutics is oversold
-
The Bollinger Bands (25) for Edgewise Therapeutics is (23.44 - 26.86), which suggest Edgewise Therapeutics is a Sell
-
The Bollinger Bands (100) for Edgewise Therapeutics is (25.14 - 31.96), which suggest Edgewise Therapeutics is a Sell
* Edgewise Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.